FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.12  |  FHIR Version n/a  User: [n/a]

3492411000001105: Ciprofloxacin 250mg/5ml oral suspension 100 ml (product)

Status: current, Not sufficiently defined by necessary conditions definition status. Date: 01-May 2006. Module: SNOMED CT United Kingdom drug extension module

Descriptions:

Id Description Lang Type Status Case? Module
22321101000001119 Ciprofloxacin 250mg/5ml oral suspension 100 ml (product) en Fully specified name Active Only initial character case insensitive SNOMED CT United Kingdom drug extension module
22321201000001114 Ciprofloxacin 250mg/5ml oral suspension 100 ml en Synonym Active Only initial character case insensitive SNOMED CT United Kingdom drug extension module

4 descendants. Search Descendants:

Expanded Value Set

Outbound Relationships Type Target Active Characteristic Refinability Group Values
Ciprofloxacin 250mg/5ml oral suspension 100 ml Has NHS dm+d (dictionary of medicines and devices) controlled drug category Controlled drug category No Controlled Drug Status true Inferred relationship Existential restriction modifier
Ciprofloxacin 250mg/5ml oral suspension 100 ml Is a Virtual medicinal product pack true Inferred relationship Existential restriction modifier
Ciprofloxacin 250mg/5ml oral suspension 100 ml Is pack of Product containing precisely ciprofloxacin 50 milligram/1 milliliter conventional release oral suspension (clinical drug) false Inferred relationship Existential restriction modifier
Ciprofloxacin 250mg/5ml oral suspension 100 ml Has active ingredient Ciprofloxacin false Inferred relationship Existential restriction modifier
Ciprofloxacin 250mg/5ml oral suspension 100 ml VMP prescribing status (attribute) VMP valid as a prescribable product true Inferred relationship Existential restriction modifier
Ciprofloxacin 250mg/5ml oral suspension 100 ml VMP non-availability indicator Available true Inferred relationship Existential restriction modifier
Ciprofloxacin 250mg/5ml oral suspension 100 ml Has manufactured dose form Conventional release oral suspension false Inferred relationship Existential restriction modifier
Ciprofloxacin 250mg/5ml oral suspension 100 ml Has VMP Product containing precisely ciprofloxacin 50 milligram/1 milliliter conventional release oral suspension (clinical drug) true Inferred relationship Existential restriction modifier
Ciprofloxacin 250mg/5ml oral suspension 100 ml Has specific active ingredient Ciprofloxacin true Inferred relationship Existential restriction modifier
Ciprofloxacin 250mg/5ml oral suspension 100 ml Has dispensed dose form Conventional release oral suspension true Inferred relationship Existential restriction modifier
Inbound Relationships Type Active Source Characteristic Refinability Group
Ciproxin 250mg/5ml suspension (Bayer Plc) 100 ml Is a True Ciprofloxacin 250mg/5ml oral suspension 100 ml Inferred relationship Existential restriction modifier
Ciproxin 250mg/5ml oral suspension (DE Pharmaceuticals) 100 ml Is a True Ciprofloxacin 250mg/5ml oral suspension 100 ml Inferred relationship Existential restriction modifier
Ciproxin 250mg/5ml oral suspension (Mawdsley-Brooks & Company Ltd) 100 ml Is a True Ciprofloxacin 250mg/5ml oral suspension 100 ml Inferred relationship Existential restriction modifier
Ciproxin 250mg/5ml oral suspension (Lexon (UK) Ltd) 100 ml Is a True Ciprofloxacin 250mg/5ml oral suspension 100 ml Inferred relationship Existential restriction modifier

This concept is not in any reference sets

Back to Start